Transcatheter aortic valve replacement (TAVR) was introduced in Taiwan in 2012. Nowadays, our team has performed more than 500 cases of transcatheter heart valve interventions (THVI), including TAVR, MitraClip, etc., in addition to conventional valve surgeries and has become one of the largest THVI centers in Asia. In general, the procedural success rate at out institution is > 98%.
Our research team has published extensively in the fields of transcatheter heart valve interventions, cardiac surgery, heart failure, coronary artery disease, and echocardiography. More than 200 publications have been published in peer-reviewed high-ranking SCI journals.
We have trained more than 100 surgeons, cardiologist, technicians, and nurses all over the world.